Activated STAT3 is a mediator and biomarker of VEGF endothelial activation - Wikidata - awgldk - TriplyDB

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

http://www.wikidata.org/entity/Q34099797

about

Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products The Complex Role of STAT3 in Viral Infections Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier.VEGF-A Stimulates STAT3 Activity via Nitrosylation of Myocardin to Regulate the Expression of Vascular Smooth Muscle Cell Differentiation Markers.Morphological and phenotypic analyses of the human placenta using whole mount immunofluorescence.Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation.Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.Identification of novel small molecules that inhibit STAT3-dependent transcription and function.6"-Debromohamacanthin A, a bis (indole) alkaloid, inhibits angiogenesis by targeting the VEGFR2-mediated PI3K/AKT/mTOR signaling pathways.The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury.Adaptive response to hypoxia and remote ischaemia pre-conditioning: a new hypoxia-inducible factors era in clinical medicine.Biochemical Effects of Exercise on a Fasciocutaneous Flap in a Rat Model.Ponicidin induces apoptosis via JAK2 and STAT3 signaling pathways in gastric carcinoma.Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells in vitro.Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.Intronic microRNA suppresses endothelial nitric oxide synthase expression and endothelial cell proliferation via inhibition of STAT3 signaling.SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo.Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies.Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.Hesperidin Inhibits Vascular Formation by Blocking the AKT/mTOR Signaling Pathways Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo.STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.Hesperetin Inhibits Vascular Formation by Suppressing of the PI3K/AKT, ERK, and p38 MAPK Signaling Pathways.In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli.Myricetin Inhibits Angiogenesis by Inducing Apoptosis and Suppressing PI3K/Akt/mTOR Signaling in Endothelial Cells.Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway.Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation.

P2860

Q26777643-6F9704BA-B5E4-4D2E-84B1-B2B6742850E1 Q26801053-2D602ADA-41C9-4CF9-9222-9CF3DA362DF0 Q28116692-04C2C2B6-BE97-4CF9-9669-C372A434EF7B Q33604925-1D7FC138-121D-4090-BEF0-6ABB3F45B4FE Q33699683-43310DA7-C996-495C-9C12-C4A2A7B1EC71 Q33752963-603277E6-8632-4C68-A5E5-2D03E17482F4 Q33826174-E2D92373-4DD1-47BA-A9A3-412F6C11B810 Q33868792-E62B17E8-FFBA-41A9-A7FD-BD45DFD8060C Q33930876-26FE1B98-E76C-424C-8936-4CCFD51215E0 Q34132787-A08FDAEB-FEBF-4F38-8143-95DF020123AA Q34157601-9E2C1F8F-0FC2-483B-B82F-688F033CC718 Q34268230-C60923C3-8F69-4B5E-929F-B914FF927833 Q34420871-01175DE3-5C65-4E8B-BC65-5A70A22DFAA4 Q34616563-A43308E6-E9CE-494C-9972-4013EB09EB51 Q34753820-0A68A413-9192-4F3F-B959-7155EAEDF9B9 Q35646263-3AE28EE6-E2ED-4AE1-B545-94DA59567914 Q35832897-AD10BCD5-4F34-40AB-B7F3-41C3402F607F Q35925825-AFD11B2A-0241-41C7-82C7-E81BF541BE24 Q36411459-8925110D-022D-4AD7-B56E-31299383A83C Q36994218-CECA95C7-01F9-456B-861A-2E15CA3E680E Q37520154-829FEF0D-A4BE-4028-A4F3-8437274A3D42 Q37780630-E8E97D9F-A9E6-4427-8D12-7AD28A45A067 Q38602621-5A830DB9-B9F1-4312-ADEF-4AAA23AE9DD7 Q38917499-05E57E74-3D76-4A4E-A945-C8239ABC91DF Q38920058-3C047340-08E4-4427-869C-5C504D43A156 Q39024619-5B1F1274-0D58-4834-BD25-68C0F6D2EC60 Q39202040-4489707B-8840-44EF-B8F2-C7B515B08301 Q39536741-C8907E4F-F529-4FDC-8075-38432B910B76 Q39628302-680EF53E-5817-440C-9E63-A0C14185F842 Q39693531-63750C52-4BDE-41A3-A1C1-D6706E7B85ED Q41310543-AF02BF9D-AF28-414D-A6FB-37010F54AC3B Q41412563-D6A7B483-B9CE-4230-8EC6-5D6F638586BF Q41867845-E6777916-F936-4EAD-9D3D-E3C29C1B364C Q42051818-33122F20-761F-43AD-9865-F58547AE9F8F Q42144822-AC619C69-048C-426F-8470-C55294AF11E1 Q43096343-ABCCD7D4-8CA5-43CB-A395-E437E7B45E52 Q45884796-B994AE57-B995-4788-8B1A-1A945333CFD7 Q47096744-92123CF0-7F0B-415F-B020-988AF5CBB7D4 Q47386296-34B1D893-C042-4DBD-AE20-907FCBEE649A Q47431399-9D15B715-71BE-4ACF-89DC-BED244BAA3D3

P2860

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

http://www.wikidata.org/entity/Q34099797

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@ast

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@en

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@nl

type

label

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@ast

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@en

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@nl

prefLabel

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@ast

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@en

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@nl

P1433

Q34099797-0C70C225-1203-49E4-8528-CCF850DBE029

P1476

Q34099797-420F1E9F-B7E1-4DEF-9417-CD8FBB8C2DE0

P2093

Q34099797-5625ACBC-D898-4DA3-8BC9-148C37F93983

Q34099797-6D1AE25F-15B1-400B-AE9E-68E6F65C730E

Q34099797-93C33ECD-3385-42D1-B1EF-1E9B61C4DDF4

Q34099797-9DB1889B-3342-4EAE-9811-CE7973B94BD9

Q34099797-9F5DBFD5-3FC4-425C-B4E5-4605DFC808A2

Q34099797-EAE4C052-F1CD-4173-9A6D-E9DCBE05EB99

P2860

Q34099797-0877D0F0-D438-4612-9DC4-A676C45ACDE7

Q34099797-1685BFB4-D033-449B-B607-A890968E0D79

Q34099797-342568C2-7EC6-4D30-BEEF-A948174D7990

Q34099797-3752B7D5-F576-4EDC-AE15-B6CC34B6797D

Q34099797-379ACC2D-558C-4D6B-8467-357DC5AF8E37

Q34099797-3A2B0837-D400-4B78-B7AD-1FB0BB018FBD

Q34099797-3C027C70-FC53-412C-A50F-329E40EA5391

Q34099797-3C9F4EFE-A73A-48A2-B844-BE013D0B34AE

Q34099797-403972FD-5918-45F1-9DE1-AECB41389AF2

Q34099797-4063C200-AC23-4BAB-B74C-5D94F5B7AC11

P304

Q34099797-8DC4E116-EE6F-4931-A358-A960E28A3937

P31

Q34099797-56315414-6ACE-44F3-A912-0B71E3539402

P356

Q34099797-B4E0FA2A-0F10-4AB1-B847-93B332F6A820

P433

Q34099797-33813FC8-B228-4F55-9BAB-8E65343E5F36

P478

Q34099797-0B014DE2-4208-473B-B23E-0B72852A6A12

P577

Q34099797-A7012D07-9DCF-4B34-81CA-FA2E9AF17191

P5875

Q34099797-A4D1888D-9DBE-4596-9D29-7B548C75C075

P698

Q34099797-D0437414-A5ED-427F-9DE5-39F9C132F758

P921

Q34099797-0ACAA43B-1368-4C29-8480-FF46852B44B7

Q34099797-87A1B8A1-5651-427F-BA25-33B4935403BF

P932

Q34099797-7306F780-CE05-4BC0-BAA9-AD72A902AEF0

P356

P1433

Cancer Biology and Therapy

P1476

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

@en

P2093

Danielle A Murphy

http://www.w3.org/2001/XMLSchema#string

Gavin Thurston

http://www.w3.org/2001/XMLSchema#string

Michael D Feldman

http://www.w3.org/2001/XMLSchema#string

Shao-Hua Chen

http://www.w3.org/2001/XMLSchema#string

Wiem Lassoued

http://www.w3.org/2001/XMLSchema#string

William M F Lee

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Angiogenesis in cancer and other diseases

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

Hypoxia--a key regulatory factor in tumour growth

P304

1994-2003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.7.12.6967

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23449077

http://www.w3.org/2001/XMLSchema#string

P698

18981713

http://www.w3.org/2001/XMLSchema#string

P921

P932

2932444

http://www.w3.org/2001/XMLSchema#string